ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000112306 | RPS12 | Ribosomal protein S12 | [
"P25398"
] | 6 | 132814569-132817564 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006124",
"HPA006365"
] | [
"S12"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Cytosol"
] | [
"Golgi apparatus",
"Vesicles"
] | [] | [] | Supported | Approved | null | 118 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 7: Non-specific - Ribosome | Cluster 25: Non-specific - Ribosome | Cluster 15: Non-specific - Protein processing | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 4,003 | 1 |
ENSG00000112308 | C6orf62 | Chromosome 6 open reading frame 62 | [
"Q9GZU0"
] | 6 | 24704861-24719998 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA030564",
"HPA030566"
] | [
"DKFZP564G182",
"FLJ12619",
"XTP12"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Supported | null | 1 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 39: Astrocytes - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 32: Retina & Lymphoid tissues - Signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 4,004 | 2 |
ENSG00000112309 | B3GAT2 | Beta-1,3-glucuronyltransferase 2 | [
"Q9NPZ5"
] | 6 | 70856679-70957060 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA012059"
] | [
"GlcAT-S"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Transferase"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 9 | null | null | null | Cluster 28: Oligodendrocytes - Mixed function | Cluster 11: Neuronal - Sensory perception | Cluster 109: Neurons - Neuronal signaling | Cluster 46: Brain & retina - Neuronal signaling | Group enriched | Detected in many | 11 | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 19 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,005 | 1 |
ENSG00000112312 | GMNN | Geminin DNA replication inhibitor | [
"O75496"
] | 6 | 24774931-24786099 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB011458",
"CAB047327",
"CAB047328",
"HPA049977",
"HPA054597"
] | [
"Gem"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle"
] | [
"DNA replication inhibitor"
] | [
"Cancer-related genes",
"Disease variant",
"Dwarfism"
] | [
"Nucleoplasm"
] | [
"Basal body",
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 34 | Yes | No | Cluster 12: Non-specific - Mitochondrial translation | Cluster 19: Astrocytes - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 52: Glandular & Luminal cells - Estrogen-regulated epithelial secretion | Cluster 8: Pancreas - Proteolysis | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 4,006 | 2 |
ENSG00000112319 | EYA4 | EYA transcriptional coactivator and phosphatase 4 | [
"O95677"
] | 6 | 133240514-133532128 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004805",
"HPA038771",
"HPA038772"
] | [
"CMD1J",
"DFNA10"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Chromatin regulator",
"Developmental protein",
"Hydrolase",
"Protein phosphatase"
] | [
"Cardiomyopathy",
"Deafness",
"Disease variant",
"Non-syndromic deafness"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Enhanced | null | 10 | No | null | null | Cluster 3: Choroid plexus - Cilium | Cluster 5: Rhabdoid - Unknown function | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 30: Skeletal muscle - Striated muscle contraction | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 4,007 | 5 |
ENSG00000112320 | SOBP | Sine oculis binding protein homolog | [
"A7XYQ1"
] | 6 | 107490106-107661306 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA029242"
] | [
"FLJ10159"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Intellectual disability"
] | [
"Nucleoplasm"
] | [
"Vesicles"
] | [] | [] | Approved | Uncertain | null | 3 | null | null | Cluster 18: Non-specific - Translation | Cluster 51: Neurons - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 91: Pituicytes/FSC - Homeostasis & neuron support | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 4,008 | 4 |
ENSG00000112333 | NR2E1 | Nuclear receptor subfamily 2 group E member 1 | [
"Q9Y466"
] | 6 | 108166022-108188805 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036954",
"HPA055642"
] | [
"TLL",
"TLX",
"XTLL"
] | [
"Nuclear receptors",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding",
"Receptor",
"Repressor"
] | [] | [
"Nuclear bodies"
] | [] | [] | [] | Approved | Uncertain | null | 8 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 72: Neuronal - Signal transduction | Cluster 11: Muller glia cells - Retinal homeostasis | Cluster 46: Brain & retina - Neuronal signaling | Group enriched | Detected in some | 56 | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in some | 9 | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 4,009 | 4 |
ENSG00000112335 | SNX3 | Sorting nexin 3 | [
"O60493"
] | 6 | 108211222-108261246 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"Grd19"
] | [
"Disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"Protein transport",
"Transport"
] | [] | [
"Microphthalmia"
] | [] | [] | [] | [] | null | null | null | 47 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 28: Non-specific - Nuclear processes | Cluster 82: Dendritic cells - Antigen presentation | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Breast Invasive Carcinoma",
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | 4,010 | 4 |
ENSG00000112337 | SLC17A2 | Solute carrier family 17 member 2 | [
"O00624"
] | 6 | 25912754-25930691 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA038270"
] | [
"NPT3"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Sodium transport",
"Symport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | null | Cluster 18: Liver cancer - Metabolism | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 45: Liver - Metabolism & Coagulation | Tissue enriched | Detected in single | 166 | Not detected | Not detected | null | Cancer enriched | Detected in some | 6 | Cell type enriched | Detected in some | 14 | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 4,011 | 3 |
ENSG00000112339 | HBS1L | HBS1 like translational GTPase | [
"Q9Y450"
] | 6 | 134960378-135103056 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA029728",
"HPA029729"
] | [
"DKFZp434g247",
"EF-1a",
"eRF3c",
"ERFS",
"HBS1",
"HSPC276",
"KIAA1038"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Protein biosynthesis",
"Translation regulation"
] | [
"Elongation factor",
"Hydrolase"
] | [] | [
"Nuclear bodies",
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 33 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 28: Oligodendrocytes - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 80: Oligodendrocytes - Myelination | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 4,012 | 7 |
ENSG00000112343 | TRIM38 | Tripartite motif containing 38 | [
"O00635"
] | 6 | 25962802-25991231 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031685"
] | [
"RNF15",
"RORET"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"Immunity",
"Innate immunity",
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Centrosome"
] | [
"Plasma membrane",
"Cell Junctions"
] | [] | [] | Approved | Approved | null | 22 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 20: Macrophages & Microglia - Immune response | Cluster 71: Lymphoma - Inflammatory response | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Papillary Cell Carcinoma"
] | 4,013 | 3 |
ENSG00000112357 | PEX7 | Peroxisomal biogenesis factor 7 | [
"O00628"
] | 6 | 136822564-136913934 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA049202"
] | [
"PTS2R",
"RD"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"Protein transport",
"Transport"
] | [] | [
"Cataract",
"Deafness",
"Disease variant",
"Ichthyosis",
"Peroxisome biogenesis disorder",
"Retinitis pigmentosa",
"Rhizomelic chondrodysplasia punctata"
] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | [] | Supported | Uncertain | null | 24 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 25: Non-specific - Transcription | Cluster 28: Non-specific - Nuclear processes | Cluster 97: Non-specific - Cellular respiration | Cluster 38: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,014 | 8 |
ENSG00000112365 | ZBTB24 | Zinc finger and BTB domain containing 24 | [
"O43167"
] | 6 | 109460632-109483239 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA017872",
"HPA049003"
] | [
"BIF1",
"KIAA0441",
"PATZ2",
"ZNF450"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [
"Cytokinetic bridge",
"Centrosome"
] | [] | [] | Approved | Uncertain | null | 67 | Yes | No | Cluster 3: Non-specific - Nuclear processes | Cluster 9: Non-specific - Receptor signaling | Cluster 28: Non-specific - Nuclear processes | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 40: Non-specific - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 4,015 | 3 |
ENSG00000112367 | FIG4 | FIG4 phosphoinositide 5-phosphatase | [
"Q92562"
] | 6 | 109690609-109878098 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017823",
"HPA068859"
] | [
"ALS11",
"CMT4J",
"dJ249I4.1",
"hSac3",
"KIAA0274",
"SAC3"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Hydrolase"
] | [
"Amyotrophic lateral sclerosis",
"Charcot-Marie-Tooth disease",
"Disease variant",
"Neurodegeneration",
"Neuropathy"
] | [
"Vesicles",
"Lipid droplets"
] | [] | [] | [] | Supported | Approved | null | 11 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 21: Non-specific - Metabolism | Cluster 28: Non-specific - Nuclear processes | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 4,016 | 8 |
ENSG00000112378 | PERP | P53 apoptosis effector related to PMP22 | [
"Q96FX8"
] | 6 | 138088505-138107419 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA022269"
] | [
"dJ496H19.1",
"KCP1",
"KRTCAP1",
"PIGPC1",
"THW"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Apoptosis",
"Cell adhesion"
] | [] | [
"Disease variant",
"Palmoplantar keratoderma"
] | [] | [] | [] | [] | null | Enhanced | null | 7 | null | null | Cluster 32: Basophils - Transcription | Cluster 42: Choroid plexus - Mitochondria | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 58: Skin - Keratinization | Group enriched | Detected in all | 4 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in many | 4 | 4 | 0 | 4 | [] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 4,017 | 4 |
ENSG00000112379 | ARFGEF3 | ARFGEF family member 3 | [
"Q5TH69"
] | 6 | 138161939-138344663 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036350"
] | [
"BIG3",
"C6orf92",
"dJ171N11.1",
"KIAA1244",
"PPP1R33"
] | [
"Predicted intracellular proteins"
] | [] | [
"Guanine-nucleotide releasing factor"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 3 | null | null | null | Cluster 34: Non-specific - Mixed function | Cluster 60: Prostate cancer - Unknown function | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 70: Non-specific - Protein processing | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 4 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma"
] | 4,018 | 2 |
ENSG00000112394 | SLC16A10 | Solute carrier family 16 member 10 | [
"Q8TF71"
] | 6 | 111087503-111231194 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016860"
] | [
"MCT10",
"TAT1"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [] | [] | [
"Vesicles",
"Cell Junctions"
] | [] | [] | [] | Supported | Approved | null | 4 | null | null | Cluster 31: T-cells - T-cell receptor | Cluster 23: Choroid plexus - Mixed function | Cluster 32: Non-specific - Cell proliferation | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 63: Non-specific - Basic cellular processes | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in all | 4 | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 0 | 0 | 0 | [] | [] | [] | 4,019 | 5 |
ENSG00000112406 | HECA | Hdc homolog, cell cycle regulator | [
"Q9UBI9"
] | 6 | 139135080-139180802 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA012581",
"HPA042313"
] | [
"dJ225E12.1",
"HDC",
"HDCL",
"hHDC"
] | [
"Predicted intracellular proteins"
] | [] | [
"Developmental protein"
] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 33: Non-specific - ATP binding | Cluster 19: Astrocytes - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 58: Skin - Keratinization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 4,020 | 7 |
ENSG00000112414 | ADGRG6 | Adhesion G protein-coupled receptor G6 | [
"Q86SQ4"
] | 6 | 142301854-142446266 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA017346"
] | [
"FLJ14937",
"GPR126"
] | [
"Disease related genes",
"G-protein coupled receptors",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Disease variant"
] | [] | [] | [] | [] | null | Approved | null | null | null | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 4,021 | 8 |
ENSG00000112419 | PHACTR2 | Phosphatase and actin regulator 2 | [
"O75167"
] | 6 | 143536845-143831185 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA031719",
"HPA031720",
"HPA031725"
] | [
"C6orf56",
"KIAA0680"
] | [
"Predicted intracellular proteins"
] | [] | [
"Actin-binding",
"Protein phosphatase inhibitor"
] | [] | [
"Golgi apparatus"
] | [
"Plasma membrane"
] | [] | [] | Approved | Approved | null | 7 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 42: Choroid plexus - Mitochondria | Cluster 64: Connective tissue cells - ECM organization | Cluster 101: Choroid plexus epithelial cells - Ion transport | Cluster 43: Placenta - Pregnancy hormone signaling | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Uterine Corpus Endometrial Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 4,022 | 8 |
ENSG00000112425 | EPM2A | EPM2A glucan phosphatase, laforin | [
"O95278"
] | 6 | 145382535-145736023 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA053643",
"HPA055468"
] | [
"LD",
"LDE"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Autophagy",
"Carbohydrate metabolism",
"Glycogen metabolism"
] | [
"Hydrolase",
"Protein phosphatase"
] | [
"Disease variant",
"Epilepsy",
"Glycogen storage disease",
"Neurodegeneration"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | null | null | 18 | null | null | Cluster 18: Non-specific - Translation | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 46: Lymphoma - Humoral immune response | Cluster 95: Tuft cells - Chemosensory signaling | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Stomach Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma",
"Stomach Adenocarcinoma"
] | 4,023 | 6 |
ENSG00000112462 | OR12D3 | Olfactory receptor family 12 subfamily D member 3 | [
"Q9UGF7"
] | 6 | 29373423-29375291 | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | Evidence at transcript level | [] | [
"hs6M1-27"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Olfaction",
"Sensory transduction"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | null | null | null | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,024 | 7 |
ENSG00000112473 | SLC39A7 | Solute carrier family 39 member 7 | [
"Q92504"
] | 6 | 33200305-33204439 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA053999"
] | [
"D6S2244E",
"H2-KE4",
"HKE4",
"KE4",
"RING5",
"ZIP7"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Transport",
"Zinc transport"
] | [] | [
"Disease variant"
] | [
"Endoplasmic reticulum"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 39 | null | null | Cluster 24: Non-specific - Transcription | Cluster 44: Non-specific - Mixed function | Cluster 63: Non-specific - Protein processing | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | 4,025 | 5 |
ENSG00000112486 | CCR6 | C-C motif chemokine receptor 6 | [
"P51684"
] | 6 | 167111807-167139141 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB006820",
"HPA014488"
] | [
"BN-1",
"CD196",
"CKR-L3",
"CMKBR6",
"DCR2",
"DRY-6",
"GPR-CY4",
"GPR29",
"STRL22"
] | [
"CD markers",
"G-protein coupled receptors",
"Human disease related genes",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | Approved | null | 8 | null | null | Cluster 16: Non-specific - Cell proliferation | null | Cluster 18: Liver cancer - Metabolism | Cluster 102: Non-specific - Mixed function | Cluster 18: Lymphoid tissue - Immune response | Tissue enriched | Detected in some | 5 | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in many | 4 | 3 | 0 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma"
] | 4,026 | 7 |
ENSG00000112494 | UNC93A | Unc-93 homolog A | [
"Q86WB7"
] | 6 | 167271169-167316014 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035729"
] | [
"dJ366N23.1",
"dJ366N23.2"
] | [
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 1 | null | null | null | null | Cluster 10: Ciliated cells - Ion channel activity | Cluster 64: Renal epithelial cells - Ion transport & homeostasis | Cluster 58: Skin - Keratinization | Group enriched | Detected in some | 10 | Group enriched | Detected in some | 5 | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 4,027 | 7 |
ENSG00000112499 | SLC22A2 | Solute carrier family 22 member 2 | [
"O15244"
] | 6 | 160171061-160277638 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008549",
"CAB068236",
"CAB068237"
] | [
"OCT2"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 4 | null | null | null | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 15: Kidney cancer - Membrane components | Cluster 88: Proximal tubular cells - Transmembrane transport | Cluster 72: Kidney - Transmembrane transport | Tissue enriched | Detected in some | 80 | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 8 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 4,028 | 6 |
ENSG00000112511 | PHF1 | PHD finger protein 1 | [
"O43189"
] | 6 | 33410399-33416453 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031038",
"HPA076579"
] | [
"MTF2L2",
"PCL1",
"TDRD19C"
] | [
"Disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"DNA damage",
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 76 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 30: White matter - Myelination | Cluster 28: Non-specific - Nuclear processes | Cluster 102: Non-specific - Mixed function | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,029 | 7 |
ENSG00000112514 | CUTA | CutA divalent cation tolerance homolog | [
"O60888"
] | 6 | 33416442-33418317 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB016787",
"HPA064369",
"HPA070199"
] | [
"ACHAP",
"C6orf82"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Plasma membrane",
"Focal adhesion sites"
] | [] | [
"Secreted to blood"
] | [
"No annotated function"
] | Approved | Approved | null | 4 | null | null | Cluster 39: T-cells - T-cell receptor | Cluster 21: Non-specific - Metabolism | Cluster 28: Non-specific - Nuclear processes | Cluster 67: Plasma cells - Plasma cell differentiation | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 4,030 | 5 |
ENSG00000112530 | PACRG | Parkin coregulated | [
"Q96M98"
] | 6 | 162727132-163315500 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA066293"
] | [
"FLJ32724",
"Glup",
"HAK005771",
"PARK2CRG"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Mid piece",
"Principal piece",
"End piece"
] | [
"Mitochondria"
] | [] | [] | Supported | Enhanced | null | 4 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 46: Brainstem - Mixed function | Cluster 56: Non-specific - Sensory perception | Cluster 50: Renal epithelial cells - Ion transport and pH regulation | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enriched | Detected in many | 5 | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 1 | 0 | 1 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 4,031 | 7 |
ENSG00000112531 | QKI | QKI, KH domain containing RNA binding | [
"Q96PU8"
] | 6 | 163414000-163578592 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA019123",
"CAB022602"
] | [
"QK3"
] | [
"Cancer-related genes",
"Predicted intracellular proteins"
] | [
"Differentiation",
"mRNA processing",
"mRNA splicing",
"mRNA transport",
"Translation regulation",
"Transport"
] | [
"Developmental protein",
"DNA-binding",
"RNA-binding"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Enhanced | Supported | 51 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 13: Oligodendrocytes - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 55: Myocytes - Oxidative muscle function | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enriched | Detected in all | 5 | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,032 | 4 |
ENSG00000112539 | C6orf118 | Chromosome 6 open reading frame 118 | [
"Q5T5N4"
] | 6 | 165279664-165309605 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA029787",
"HPA029789"
] | [
"bA85G2.1",
"MGC23884"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Uncertain | Approved | null | null | null | null | null | Cluster 3: Choroid plexus - Cilium | Cluster 10: Ciliated cells - Ion channel activity | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Group enriched | Detected in some | 5 | Not detected | Not detected | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,033 | 4 |
ENSG00000112541 | PDE10A | Phosphodiesterase 10A | [
"Q9Y233"
] | 6 | 165327287-165988117 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB045998",
"HPA047200"
] | [] | [
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Allosteric enzyme",
"Hydrolase"
] | [
"Disease variant",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Supported | null | 1 | null | null | null | Cluster 33: Neurons - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 72: Kidney - Transmembrane transport | Low tissue specificity | Detected in some | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 4,034 | 2 |
ENSG00000112559 | MDFI | MyoD family inhibitor | [
"Q99750"
] | 6 | 41636882-41654244 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA049973"
] | [
"I-mfa"
] | [
"Predicted intracellular proteins"
] | [
"Differentiation"
] | [
"Developmental protein"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 347 | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | 4,035 | 3 |
ENSG00000112561 | TFEB | Transcription factor EB | [
"P19484"
] | 6 | 41683978-41736259 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA067082"
] | [
"bHLHe35",
"TCFEB"
] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Adaptive immunity",
"Autophagy",
"Immunity",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Cytosol"
] | [] | [] | [] | Supported | null | null | 9 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 11: White matter - Signal transduction | Cluster 55: Lymphoma - Immune response | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 6 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 4,036 | 3 |
ENSG00000112562 | SMOC2 | SPARC related modular calcium binding 2 | [
"Q9H3U7"
] | 6 | 168441151-168673445 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"SMAP2"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [] | [] | [
"Secreted to extracellular matrix"
] | [
"No annotated function"
] | null | null | null | 1 | null | null | null | Cluster 42: Choroid plexus - Mitochondria | Cluster 70: DU4475 - Unknown function | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Bladder Urothelial Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 4,037 | 9 |
ENSG00000112576 | CCND3 | Cyclin D3 | [
"P30281"
] | 6 | 41934934-42050357 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000116",
"HPA042871"
] | [] | [
"Cancer-related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Transcription",
"Transcription regulation"
] | [
"Cyclin"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 55 | null | Yes | Cluster 41: Basophils - Unknown function | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 6: Leukemia - Signal transduction | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Thyroid Carcinoma"
] | [] | [
"Thyroid Carcinoma"
] | 4,038 | 3 |
ENSG00000112578 | BYSL | Bystin like | [
"Q13895"
] | 6 | 41921499-41933046 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031217",
"HPA031219"
] | [
"Enp1"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Ribosome biogenesis"
] | [] | [] | [
"Nucleoli",
"Nucleoli rim",
"Mitotic chromosome"
] | [
"Nucleoplasm"
] | [] | [] | Enhanced | Enhanced | null | 288 | Yes | No | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 27: Non-specific - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 17: Non-specific - RNA processing | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 2 | 2 | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | 4,039 | 2 |
ENSG00000112584 | FAM120B | Family with sequence similarity 120B | [
"Q96EK7"
] | 6 | 170290703-170407067 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037518",
"HPA037519"
] | [
"CCPG",
"KIAA1838",
"PGCC1",
"SAN1"
] | [
"Predicted intracellular proteins"
] | [
"Differentiation",
"Transcription",
"Transcription regulation"
] | [
"Activator"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 10 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 26: Oligodendrocytes - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 4 | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,040 | 7 |
ENSG00000112599 | GUCA1B | Guanylate cyclase activator 1B | [
"Q9UMX6"
] | 6 | 42183284-42194956 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA055479"
] | [
"GCAP2",
"RP48"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"Sensory transduction",
"Vision"
] | [] | [
"Disease variant",
"Retinitis pigmentosa"
] | [
"Microtubules",
"Primary cilium"
] | [
"Nucleoplasm",
"Nuclear membrane",
"Basal body"
] | [] | [] | Approved | Enhanced | null | null | null | null | null | Cluster 13: Oligodendrocytes - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 42: Retina - Visual perception | Tissue enriched | Detected in many | 79 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in many | 37 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 4,042 | 5 |
ENSG00000112619 | PRPH2 | Peripherin 2 | [
"P23942"
] | 6 | 42696598-42722597 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029458"
] | [
"CACD2",
"rd2",
"RDS",
"RP7",
"TSPAN22"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Cell adhesion",
"Sensory transduction",
"Vision"
] | [] | [
"Cone-rod dystrophy",
"Disease variant",
"Retinitis pigmentosa"
] | [] | [] | [] | [] | null | Enhanced | null | 2 | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 1: Neuronal - Visual perception | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 42: Retina - Visual perception | Tissue enriched | Detected in many | 48 | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Group enriched | Detected in many | 13 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,043 | 4 |
ENSG00000112640 | PPP2R5D | Protein phosphatase 2 regulatory subunit B'delta | [
"Q14738"
] | 6 | 42984553-43012342 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029045",
"HPA029046"
] | [
"B56D",
"B56delta"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant",
"Intellectual disability"
] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 26 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 28: Non-specific - Nuclear processes | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 4,045 | 9 |
ENSG00000112651 | MRPL2 | Mitochondrial ribosomal protein L2 | [
"Q5T653"
] | 6 | 43054029-43059438 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA007455",
"HPA064814"
] | [
"CGI-22",
"MRP-L14",
"RPML14"
] | [
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Mitochondria"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 133 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 37: Neurons - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 15: Non-specific - Protein processing | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Bladder Urothelial Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 4,046 | 5 |
ENSG00000112655 | PTK7 | Protein tyrosine kinase 7 (inactive) | [
"Q13308"
] | 6 | 43076307-43161719 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA003222"
] | [
"CCK4"
] | [
"Enzymes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Cell adhesion",
"Wnt signaling pathway"
] | [
"Receptor"
] | [] | [
"Plasma membrane",
"Cytosol"
] | [
"Vesicles"
] | [
"Secreted to blood"
] | [
"Receptor"
] | Approved | Approved | null | 22 | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 36: Choroid plexus - Mixed function | Cluster 32: Non-specific - Cell proliferation | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in some | 10 | 1 | 0 | 1 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | 4,047 | 9 |
ENSG00000112658 | SRF | Serum response factor | [
"P11831"
] | 6 | 43171269-43181506 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001819",
"CAB005416"
] | [
"MCM1"
] | [
"Essential proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Supported | null | 33 | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 51: Neurons - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 0 | 0 | 0 | [] | [] | [] | 4,048 | 7 |
ENSG00000112659 | CUL9 | Cullin 9 | [
"Q8IWT3"
] | 6 | 43182184-43224587 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA016434",
"HPA052004"
] | [
"H7AP1",
"KIAA0708",
"PARC"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 11 | No | No | Cluster 33: Non-specific - ATP binding | Cluster 32: Cerebral cortex - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 19 | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 4,049 | 3 |
ENSG00000112667 | DNPH1 | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | [
"O43598"
] | 6 | 43225629-43229481 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029675",
"HPA029676"
] | [
"C6orf108",
"dJ330M21.3",
"rcl"
] | [
"Predicted intracellular proteins"
] | [
"Nucleotide metabolism"
] | [
"Glycosidase",
"Hydrolase"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 5 | No | No | Cluster 33: Non-specific - ATP binding | Cluster 36: Choroid plexus - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 1: Enterocytes - Absorption and Digestion | Cluster 72: Kidney - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 4,050 | 5 |
ENSG00000112679 | DUSP22 | Dual specificity phosphatase 22 | [
"Q9NRW4"
] | 6 | 291630-351355 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA031394"
] | [
"JKAP",
"JSP1",
"MKPX",
"VHX"
] | [
"Enzymes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Immunity"
] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | [] | Approved | Approved | null | 3 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Colon Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 4,051 | 6 |
ENSG00000112685 | EXOC2 | Exocyst complex component 2 | [
"Q96KP1"
] | 6 | 485154-693139 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA032093"
] | [
"FLJ11026",
"Sec5",
"SEC5L1"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"RAS pathway related proteins",
"Transporters"
] | [
"Exocytosis",
"Protein transport",
"Transport"
] | [] | [
"Disease variant",
"Intellectual disability",
"Neurodegeneration"
] | [
"Vesicles"
] | [] | [] | [] | Approved | null | null | 37 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 30: White matter - Myelination | Cluster 71: Lymphoma - Inflammatory response | Cluster 7: Non-specific - Transcription | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,052 | 8 |
ENSG00000112695 | COX7A2 | Cytochrome c oxidase subunit 7A2 | [
"P14406"
] | 6 | 75237675-75250323 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"COX7AL",
"COXVIIa-L"
] | [
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [] | [
"Oxidoreductase"
] | [] | [] | [] | [] | [] | null | null | null | 11 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 21: Non-specific - Metabolism | Cluster 28: Non-specific - Nuclear processes | Cluster 97: Non-specific - Cellular respiration | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | 4,053 | 2 |
ENSG00000112697 | TMEM30A | Transmembrane protein 30A | [
"Q9NV96"
] | 6 | 75252924-75284948 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA014561"
] | [
"C6orf67",
"CDC50A",
"FLJ10856"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Lipid transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 25 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 21: Non-specific - Metabolism | Cluster 64: Connective tissue cells - ECM organization | Cluster 17: Non-specific - RNA processing | Cluster 73: Brain - Neuronal signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 4,054 | 8 |
ENSG00000112699 | GMDS | GDP-mannose 4,6-dehydratase | [
"O60547"
] | 6 | 1623806-2245605 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031528"
] | [
"GMD",
"SDR3E1"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Lyase"
] | [] | [] | [] | [] | [] | null | Enhanced | null | 7 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 23: Choroid plexus - Mixed function | Cluster 2: Mucus-secreting cells - Unknown function | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 17: Intestine - Digestion | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | 4,055 | 4 |
ENSG00000112701 | SENP6 | SUMO specific peptidase 6 | [
"Q9GZR1"
] | 6 | 75601509-75718281 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024376"
] | [
"KIAA0797",
"SUSP1"
] | [
"Enzymes",
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [
"Hydrolase",
"Protease",
"Thiol protease"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 10 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 16: Non-specific - Transcription | Cluster 28: Non-specific - Nuclear processes | Cluster 7: Non-specific - Transcription | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Uterine Corpus Endometrial Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 4,056 | 2 |
ENSG00000112706 | IMPG1 | Interphotoreceptor matrix proteoglycan 1 | [
"Q17R60"
] | 6 | 75921114-76072678 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027142",
"HPA030332",
"HPA030333"
] | [
"GP147",
"IPM150",
"SPACR"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Heparin-binding",
"Receptor"
] | [
"Disease variant",
"Retinitis pigmentosa"
] | [
"Plasma membrane",
"Microtubules",
"Mid piece",
"Principal piece",
"End piece"
] | [] | [
"Secreted in other tissues"
] | [
"Receptor"
] | Uncertain | Enhanced | null | null | null | null | null | Cluster 34: Non-specific - Mixed function | Cluster 11: Neuronal - Sensory perception | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 42: Retina - Visual perception | Tissue enriched | Detected in some | 93 | Cancer enhanced | Detected in single | null | Not detected | Not detected | null | Group enriched | Detected in some | 23 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,057 | 7 |
ENSG00000112715 | VEGFA | Vascular endothelial growth factor A | [
"P15692"
] | 6 | 43770184-43786487 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB005429",
"CAB039240",
"HPA069116",
"CAB069907"
] | [
"VEGF",
"VEGF-A",
"VPF"
] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins",
"RAS pathway related proteins"... | [
"Angiogenesis",
"Differentiation"
] | [
"Developmental protein",
"Growth factor",
"Heparin-binding",
"Mitogen"
] | [
"Cancer-related genes",
"FDA approved drug targets"
] | [] | [] | [
"Secreted to blood"
] | [
"Growth factor"
] | null | Supported | null | 24 | null | null | null | Cluster 42: Choroid plexus - Mitochondria | Cluster 15: Kidney cancer - Membrane components | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 48: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 6 | 0 | 6 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 4,058 | 4 |
ENSG00000112739 | PRPF4B | Pre-mRNA processing factor 4B | [
"Q13523"
] | 6 | 4021267-4064983 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA020638"
] | [
"KIAA0536",
"PR4H",
"Prp4"
] | [
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Supported | Approved | null | 162 | null | null | null | Cluster 55: Non-specific - Transcription | Cluster 56: Non-specific - Sensory perception | Cluster 17: Non-specific - RNA processing | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Head and Neck Squamous Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 4,059 | 3 |
ENSG00000112742 | TTK | TTK protein kinase | [
"P33981"
] | 6 | 80003887-80042527 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB010166",
"CAB013229",
"HPA058657"
] | [
"CT96",
"MPH1",
"MPS1",
"MPS1L1"
] | [
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase",
"Tyrosine-protein kinase"
] | [] | [
"Cytosol"
] | [
"Nucleoli"
] | [] | [] | Approved | Enhanced | null | 17 | null | Yes | null | null | Cluster 28: Non-specific - Nuclear processes | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Group enriched | Detected in many | 6 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 6 | 6 | 3 | [] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 4,060 | 3 |
ENSG00000112759 | SLC29A1 | Solute carrier family 29 member 1 (Augustine blood group) | [
"Q99808"
] | 6 | 44219553-44234142 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA012384"
] | [
"ENT1"
] | [
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 15 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 24: Neurons - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in all | 26 | 1 | 0 | 1 | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 4,061 | 7 |
ENSG00000112761 | CCN6 | Cellular communication network factor 6 | [
"O95389"
] | 6 | 112054075-112069686 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA064196"
] | [
"WISP-3",
"WISP3"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted secreted proteins"
] | [] | [
"Growth factor"
] | [
"Disease variant"
] | [
"Mitochondria"
] | [] | [
"Secreted to extracellular matrix"
] | [
"Growth factor"
] | Supported | null | null | 3 | null | null | null | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 50: Epididymis - Male reproductive secretion | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,062 | 5 |
ENSG00000112763 | BTN2A1 | Butyrophilin subfamily 2 member A1 | [
"Q7KYR7"
] | 6 | 26457904-26476621 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA019208"
] | [
"BT2.1",
"BTF1",
"BTN2.1"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 25: Non-specific - Transcription | Cluster 28: Non-specific - Nuclear processes | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,063 | 3 |
ENSG00000112769 | LAMA4 | Laminin subunit alpha 4 | [
"Q16363"
] | 6 | 112107931-112254939 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA015693",
"CAB078156"
] | [
"LAMA3"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Cell adhesion"
] | [] | [
"Cardiomyopathy",
"Disease variant"
] | [
"Plasma membrane",
"Cytosol"
] | [] | [
"Secreted to extracellular matrix"
] | [
"Cell adhesion"
] | Approved | Enhanced | null | 3 | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 69: Skin cancer - ECM organization | Cluster 89: Adipocytes - Lipid metabolism | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | 4,064 | 6 |
ENSG00000112773 | TENT5A | Terminal nucleotidyltransferase 5A | [
"Q96IP4"
] | 6 | 81491439-81752774 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA051067",
"HPA067140"
] | [
"C6orf37",
"FAM46A",
"FLJ20037"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Nucleotidyltransferase",
"Transferase"
] | [
"Disease variant",
"Osteogenesis imperfecta"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 14 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 15: Bone marrow - Innate immune response | Group enriched | Detected in all | 4 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 4,065 | 9 |
ENSG00000112782 | CLIC5 | Chloride intracellular channel 5 | [
"Q9NZA1"
] | 6 | 45880827-46080348 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA074371"
] | [
"DFNB102"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"Hearing",
"Ion transport",
"Sensory transduction",
"Transport",
"Vision"
] | [
"Chloride channel",
"Ion channel",
"Oxidoreductase",
"Voltage-gated channel"
] | [
"Deafness",
"Non-syndromic deafness"
] | [
"Plasma membrane"
] | [
"Nuclear speckles"
] | [] | [] | Supported | null | null | 1 | null | null | Cluster 1: T-cells - Unknown function | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 15: Kidney cancer - Membrane components | Cluster 57: Podocytes - Glomerular filtration | Cluster 62: Skeletal muscle - Muscle contraction | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Group enriched | Detected in many | 4 | Immune cell enhanced | Detected in some | null | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 4,066 | 9 |
ENSG00000112787 | FBRSL1 | Fibrosin like 1 | [
"Q9HCM7"
] | 12 | 132489551-132585188 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA049880"
] | [
"KIAA1545"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Approved | Enhanced | null | 12 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 15: Non-specific - Transcription | Cluster 38: Non-specific - Transcription | Cluster 82: Dendritic cells - Antigen presentation | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 3 | 0 | 3 | [
"Pancreatic Adenocarcinoma",
"Rectum Adenocarcinoma"
] | [
"Prostate Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma",
"Prostate Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 4,067 | 3 |
ENSG00000112796 | ENPP5 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 | [
"Q9UJA9"
] | 6 | 46159185-46170980 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016902"
] | [] | [
"Predicted membrane proteins"
] | [] | [
"Hydrolase"
] | [] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | Approved | Enhanced | null | 3 | null | null | Cluster 1: T-cells - Unknown function | Cluster 1: Neurons - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 10: Epididymal principal cells - Sperm maturation microenvironment | Cluster 22: Epididymis - Mixed function | Tissue enriched | Detected in many | 5 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 4,068 | 3 |
ENSG00000112799 | LY86 | Lymphocyte antigen 86 | [
"O95711"
] | 6 | 6588108-6654983 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB025000",
"HPA044895"
] | [
"dJ80N2.1",
"MD-1"
] | [
"Predicted secreted proteins"
] | [
"Immunity",
"Inflammatory response",
"Innate immunity"
] | [] | [] | [] | [] | [
"Secreted to blood"
] | [
"Immunity"
] | null | Approved | null | 119 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 74: Microglia - Neuroimmunity & neuroinflammation | Cluster 18: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 4 | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 4,069 | 1 |
ENSG00000112812 | PRSS16 | Serine protease 16 | [
"Q9NQE7"
] | 6 | 27247701-27256624 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [] | [
"TSSP"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Hydrolase",
"Protease",
"Serine protease"
] | [] | [] | [] | [
"Secreted in other tissues"
] | [
"Enzyme"
] | null | null | null | null | null | null | Cluster 24: Non-specific - Transcription | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 80: Thymus - Adaptive immune response | Tissue enriched | Detected in many | 57 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 1 | 0 | 1 | [
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Ovary Serous Cystadenocarcinoma"
] | 4,070 | 9 |
ENSG00000112818 | MEP1A | Meprin A subunit alpha | [
"Q16819"
] | 6 | 46793389-46839778 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB025163",
"HPA029416"
] | [
"PPHA"
] | [
"Enzymes",
"Plasma proteins",
"Predicted membrane proteins"
] | [] | [
"Hydrolase",
"Metalloprotease",
"Protease"
] | [] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | null | null | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 1: Enterocytes - Absorption and Digestion | Cluster 7: Small intestine - Absorption and Digestion | Tissue enriched | Detected in some | 101 | Group enriched | Detected in some | 13 | Group enriched | Detected in some | 5 | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 4,071 | 6 |
ENSG00000112837 | TBX18 | T-box transcription factor 18 | [
"O95935"
] | 6 | 84687351-84764598 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006807"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding",
"Repressor"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | null | null | 5 | null | null | null | Cluster 42: Choroid plexus - Mitochondria | Cluster 64: Connective tissue cells - ECM organization | Cluster 22: Non-specific - Basic cellular functions | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,072 | 2 |
ENSG00000112851 | ERBIN | Erbb2 interacting protein | [
"Q96RT1"
] | 5 | 65883128-66082546 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048606",
"HPA059863"
] | [
"ERBB2IP",
"LAP2"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane",
"Cell Junctions"
] | [] | [] | [] | Supported | Approved | null | 42 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 13: Oligodendrocytes - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 3: Oligodendrocytes - Myelination | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 4,073 | 2 |
ENSG00000112852 | PCDHB2 | Protocadherin beta 2 | [
"Q9Y5E7"
] | 5 | 141094606-141098703 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA007548"
] | [
"PCDH-BETA2"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Enhanced | null | 1 | null | null | null | Cluster 34: Non-specific - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 57: Testis - Spermatogenesis | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Stomach Adenocarcinoma"
] | [
"Stomach Adenocarcinoma"
] | 4,074 | 1 |
ENSG00000112855 | HARS2 | Histidyl-tRNA synthetase 2, mitochondrial | [
"P49590"
] | 5 | 140691430-140699305 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA035941",
"HPA075303"
] | [
"HARSL",
"HARSR",
"HO3"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Protein biosynthesis"
] | [
"Aminoacyl-tRNA synthetase",
"Ligase"
] | [
"Deafness",
"Disease variant"
] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 62 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 21: Non-specific - Metabolism | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 7: Non-specific - Transcription | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,075 | 2 |
ENSG00000112874 | NUDT12 | Nudix hydrolase 12 | [
"Q9BQG2"
] | 5 | 103548855-103562790 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045449"
] | [
"DKFZP761I172"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [] | [] | [] | [] | [] | null | Supported | null | 8 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 65: Non-specific - Unknown function | Cluster 16: Prostatic glandular cells - Androgen response & seminal fluid | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in single | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,076 | 1 |
ENSG00000112877 | CEP72 | Centrosomal protein 72 | [
"Q9P209"
] | 5 | 612340-667168 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA058235",
"HPA074879"
] | [
"FLJ10565",
"KIAA1519"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Centriolar satellite",
"Centrosome"
] | [
"Basal body"
] | [] | [] | Supported | Approved | null | 33 | null | null | Cluster 24: Non-specific - Transcription | Cluster 34: Non-specific - Mixed function | Cluster 29: Non-specific - Unknown function | Cluster 61: Schwann cells & Melanocytes - Mixed function | Cluster 67: Testis - Mixed function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 4,077 | 7 |
ENSG00000112902 | SEMA5A | Semaphorin 5A | [
"Q13591"
] | 5 | 9035033-9546075 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA004632"
] | [
"SEMAF",
"semF"
] | [
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Differentiation",
"Neurogenesis"
] | [
"Developmental protein"
] | [] | [] | [] | [] | [] | null | Approved | null | null | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 29: Forebrain - Mixed function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 14: Oligodendrocyte progenitor cells - Development & myelination | Cluster 72: Kidney - Transmembrane transport | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 12 | 2 | 2 | 1 | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 4,079 | 8 |
ENSG00000112936 | C7 | Complement C7 | [
"P10643"
] | 5 | 40909492-41020216 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA001465"
] | [] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Complement alternate pathway",
"Complement pathway",
"Cytolysis",
"Immunity",
"Innate immunity"
] | [] | [
"Cancer-related genes",
"Disease variant"
] | [] | [] | [
"Secreted to blood"
] | [
"Complement pathway"
] | null | Approved | null | 1 | null | null | null | Cluster 8: Immune cells - Immune response | Cluster 44: Connective tissue cells - ECM organization | Cluster 108: Fibroblasts - ECM organization | Cluster 4: Adrenal gland - Steroid metabolism | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 12 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Rectum Adenocarcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 4,080 | 5 |
ENSG00000112941 | TENT4A | Terminal nucleotidyltransferase 4A | [
"Q5XG87"
] | 5 | 6713432-6757044 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045487",
"HPA046742"
] | [
"LAK-1",
"PAPD7",
"POLK",
"POLS",
"TRF4",
"TRF4-1"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"mRNA processing"
] | [
"Nucleotidyltransferase",
"Transferase"
] | [] | [
"Nucleoplasm"
] | [
"Nuclear membrane",
"Golgi apparatus"
] | [] | [] | Supported | Enhanced | null | 1 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 2: Neurons - Nucleosome | Cluster 29: Non-specific - Unknown function | Cluster 82: Dendritic cells - Antigen presentation | Cluster 15: Bone marrow - Innate immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in single | null | 3 | 0 | 3 | [
"Lung Squamous Cell Carcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Lung Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 4,081 | 1 |
ENSG00000112964 | GHR | Growth hormone receptor | [
"P10912"
] | 5 | 42423439-42721878 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045339",
"HPA057705"
] | [
"GHBP"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Endocytosis"
] | [
"Receptor"
] | [
"Disease variant",
"Dwarfism",
"FDA approved drug targets"
] | [
"Plasma membrane",
"Cytosol",
"Cytoplasmic bodies"
] | [] | [
"Secreted to blood"
] | [
"Receptor"
] | Supported | Enhanced | null | 31 | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 3: Rhabdoid - Membrane components | Cluster 89: Adipocytes - Lipid metabolism | Cluster 45: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Group enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 4 | 4 | 2 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Thyroid Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | 4,082 | 8 |
ENSG00000112972 | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | [
"Q01581"
] | 5 | 43287470-43313512 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB032907",
"HPA036913",
"HPA036914"
] | [
"HMGCS"
] | [
"Enzymes",
"Essential proteins",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cholesterol biosynthesis",
"Cholesterol metabolism",
"Lipid biosynthesis",
"Lipid metabolism",
"Steroid biosynthesis",
"Steroid metabolism",
"Sterol biosynthesis",
"Sterol metabolism"
] | [
"Transferase"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Supported | Approved | null | 15 | No | No | Cluster 29: Non-specific - Unknown function | Cluster 49: Hindbrain - Mixed function | Cluster 66: Non-specific - Mitochondria | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 45: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,083 | 4 |
ENSG00000112977 | DAP | Death associated protein | [
"P51397"
] | 5 | 10679230-10761234 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA029456"
] | [
"DAP1"
] | [
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Autophagy",
"Translation regulation"
] | [] | [] | [
"Vesicles",
"Mitochondria"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Uncertain | null | 3 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 8: Immune cells - Immune response | Cluster 29: Non-specific - Unknown function | Cluster 4: Breast lactating luminal cells - Lactation | Cluster 8: Pancreas - Proteolysis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 4,084 | 6 |
ENSG00000112981 | NME5 | NME/NM23 family member 5 | [
"P56597"
] | 5 | 138115175-138139443 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044555",
"HPA058103"
] | [
"nm23-H5",
"RSPH23"
] | [
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Differentiation",
"Spermatogenesis"
] | [
"Developmental protein",
"Hydrolase"
] | [
"Ciliopathy",
"Primary ciliary dyskinesia"
] | [
"Cytosol"
] | [
"Plasma membrane",
"Primary cilium"
] | [] | [] | Approved | Enhanced | null | 10 | null | null | null | Cluster 17: Choroid plexus - Cilium | Cluster 10: Ciliated cells - Ion channel activity | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 4,085 | 8 |
ENSG00000112984 | KIF20A | Kinesin family member 20A | [
"O95235"
] | 5 | 138178719-138187723 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036909",
"HPA036910"
] | [
"MKLP2",
"RAB6KIFL"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [
"Motor protein"
] | [
"Cardiomyopathy",
"Disease variant"
] | [
"Nucleoplasm",
"Cytokinetic bridge",
"Cleavage furrow",
"Mitotic spindle"
] | [] | [] | [] | Approved | Approved | null | 26 | Yes | Yes | Cluster 16: Non-specific - Cell proliferation | Cluster 12: Non-specific - Vasculature | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in some | 12 | 6 | 6 | 3 | [] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 4,087 | 3 |
ENSG00000112996 | MRPS30 | Mitochondrial ribosomal protein S30 | [
"Q9NP92"
] | 5 | 44808947-44820428 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA018686",
"HPA021149"
] | [
"PAP",
"PDCD9"
] | [
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [] | [] | [] | [] | null | Approved | null | 93 | null | null | Cluster 16: Non-specific - Cell proliferation | Cluster 53: Neurons - Mixed function | Cluster 29: Non-specific - Unknown function | Cluster 17: Non-specific - RNA processing | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 4,089 | 5 |
ENSG00000113013 | HSPA9 | Heat shock protein family A (Hsp70) member 9 | [
"P38646"
] | 5 | 138553756-138575675 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000898",
"CAB005219"
] | [
"GRP75",
"HSPA9B",
"mot-2",
"mthsp75",
"PBP74"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Chaperone",
"Hydrolase"
] | [
"Disease variant",
"Dwarfism"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Supported | null | 118 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 21: Non-specific - Metabolism | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 103: Non-specific - Basic cellular processes | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Colon Adenocarcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 4,090 | 5 |
ENSG00000113048 | MRPS27 | Mitochondrial ribosomal protein S27 | [
"Q92552"
] | 5 | 72214953-72321717 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA071751"
] | [
"KIAA0264"
] | [
"Essential proteins",
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [
"Translation regulation"
] | [
"Ribonucleoprotein",
"Ribosomal protein",
"RNA-binding",
"rRNA-binding",
"tRNA-binding"
] | [] | [
"Mitochondria"
] | [
"Nucleoli"
] | [] | [] | Supported | Approved | null | 122 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 21: Non-specific - Metabolism | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,091 | 4 |
ENSG00000113068 | PFDN1 | Prefoldin subunit 1 | [
"O60925"
] | 5 | 140245035-140303113 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006499"
] | [
"PFD1"
] | [
"Essential proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Chaperone"
] | [] | [
"Plasma membrane",
"Cytosol"
] | [
"Nucleoli"
] | [] | [] | Approved | Approved | null | 58 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 45: Non-specific - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 83: Epicardial mesothelial cells - Basic cellular functions | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in all | 31 | Low immune cell specificity | Detected in all | null | 5 | 0 | 5 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 4,092 | 2 |
ENSG00000113070 | HBEGF | Heparin binding EGF like growth factor | [
"Q99075"
] | 5 | 140332843-140346603 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA019793",
"HPA053243"
] | [
"DTR",
"DTS",
"HEGFL"
] | [
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [] | [
"Growth factor",
"Heparin-binding",
"Receptor"
] | [] | [
"Golgi apparatus"
] | [
"Vesicles"
] | [
"Secreted to blood"
] | [
"Growth factor"
] | Approved | Uncertain | null | 16 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 11: White matter - Signal transduction | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 100: Stratified epithelial cells - Barrier functions | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 5 | 2 | 0 | 2 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 4,093 | 3 |
ENSG00000113088 | GZMK | Granzyme K | [
"P49863"
] | 5 | 55024256-55034570 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA059953",
"HPA063181",
"HPA065895"
] | [
"PRSS",
"TRYP2"
] | [
"Enzymes",
"Predicted secreted proteins"
] | [] | [
"Hydrolase",
"Protease",
"Serine protease"
] | [] | [
"Golgi apparatus"
] | [] | [
"Secreted to blood"
] | [
"Enzyme"
] | Approved | Enhanced | null | 3 | null | null | Cluster 1: T-cells - Unknown function | null | Cluster 6: Leukemia - Signal transduction | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 18: Lymphoid tissue - Immune response | Tissue enriched | Detected in many | 9 | Not detected | Not detected | null | Cancer enhanced | Detected in all | null | Group enriched | Detected in some | 14 | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | 4,096 | 4 |
ENSG00000113108 | APBB3 | Amyloid beta precursor protein binding family B member 3 | [
"O95704"
] | 5 | 140558268-140564781 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005571",
"HPA076196"
] | [
"FE65L2"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nuclear bodies",
"Actin filaments"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 17 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 27: Cerebellum - Synaptic function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 4 | 0 | 4 | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 4,098 | 7 |
ENSG00000113119 | TMCO6 | Transmembrane and coiled-coil domains 6 | [
"Q96DC7"
] | 5 | 140639435-140645408 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037473",
"HPA037474"
] | [
"FLJ39769",
"PRO1580"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Uncertain | null | 7 | No | No | Cluster 35: Neutrophils - Protein binding | Cluster 20: Macrophages & Microglia - Immune response | Cluster 47: Leukemia - Hemostasis | Cluster 18: Adrenal cortex cells - Steroidogensis | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 4,099 | 1 |
ENSG00000113161 | HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | [
"P04035"
] | 5 | 75336329-75364001 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008338",
"CAB016797",
"CAB078688"
] | [] | [
"Enzymes",
"Essential proteins",
"FDA approved drug targets",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Cholesterol biosynthesis",
"Cholesterol metabolism",
"Lipid biosynthesis",
"Lipid metabolism",
"Steroid biosynthesis",
"Steroid metabolism",
"Sterol biosynthesis",
"Sterol metabolism"
] | [
"Oxidoreductase"
] | [
"Disease variant",
"FDA approved drug targets",
"Limb-girdle muscular dystrophy"
] | [] | [] | [] | [] | null | Supported | null | 10 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 24: Neurons - Mixed function | Cluster 66: Non-specific - Mitochondria | Cluster 52: Glandular & Luminal cells - Estrogen-regulated epithelial secretion | Cluster 76: Non-specific - Metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 4,102 | 1 |
ENSG00000113163 | CERT1 | Ceramide transporter 1 | [
"Q9Y5P4"
] | 5 | 75356345-75512138 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035645",
"HPA042608"
] | [
"CERT",
"COL4A3BP",
"GPBP",
"STARD11"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Lipid transport",
"Transport"
] | [] | [
"Disease variant",
"Intellectual disability"
] | [
"Golgi apparatus"
] | [
"Nucleoplasm"
] | [] | [] | Enhanced | Enhanced | null | 19 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 55: Non-specific - Transcription | Cluster 69: Skin cancer - ECM organization | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,103 | 3 |
ENSG00000113194 | FAF2 | Fas associated factor family member 2 | [
"Q96CS3"
] | 5 | 176447628-176510074 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA065968",
"HPA071246",
"HPA073828"
] | [
"ETEA",
"KIAA0887",
"UBXD8",
"UBXN3B"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Unfolded protein response"
] | [] | [] | [
"Lipid droplets"
] | [
"Endoplasmic reticulum"
] | [] | [] | Enhanced | Approved | null | 75 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 1: Neurons - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 48: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 4,104 | 2 |
ENSG00000113196 | HAND1 | Heart and neural crest derivatives expressed 1 | [
"O96004"
] | 5 | 154474972-154478227 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA040925",
"HPA075313"
] | [
"bHLHa27",
"eHand",
"Hxt",
"Thing1"
] | [
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Nuclear membrane",
"Nuclear bodies"
] | [] | [] | Approved | Uncertain | null | 5 | null | null | null | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 108: Fibroblasts - ECM organization | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in some | null | Group enriched | Detected in some | 8 | Cancer enhanced | Detected in some | null | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,105 | 4 |
ENSG00000113205 | PCDHB3 | Protocadherin beta 3 | [
"Q9Y5E6"
] | 5 | 141100473-141103827 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA050296"
] | [
"PCDH-BETA3"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [
"Vesicles"
] | [] | [] | [] | Supported | Uncertain | null | 83 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 76: Pancreatic endocrine cells - Endocrine signaling | Cluster 57: Testis - Spermatogenesis | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,106 | 9 |
ENSG00000113209 | PCDHB5 | Protocadherin beta 5 | [
"Q9Y5E4"
] | 5 | 141135206-141138615 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA013191",
"HPA067473"
] | [
"DKFZp586B0217",
"PCDH-BETA5"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [
"Plasma membrane"
] | [
"Vesicles"
] | [] | [] | Approved | Approved | null | 4 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 15: Kidney cancer - Membrane components | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 65: Brain - Transcription | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Stomach Adenocarcinoma"
] | [
"Stomach Adenocarcinoma"
] | 4,107 | 5 |
ENSG00000113211 | PCDHB6 | Protocadherin beta 6 | [
"Q9Y5E3"
] | 5 | 141150057-141153287 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA029566",
"HPA075308"
] | [
"PCDH-BETA6"
] | [
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 15: Kidney cancer - Membrane components | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in some | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,108 | 3 |
ENSG00000113212 | PCDHB7 | Protocadherin beta 7 | [
"Q9Y5E2"
] | 5 | 141172644-141176383 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA059271"
] | [
"PCDH-BETA7"
] | [
"Plasma proteins",
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [] | [] | [] | [] | null | Approved | null | 19 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 15: Kidney cancer - Membrane components | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in many | 4 | Group enriched | Detected in some | 6 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 4,109 | 1 |
ENSG00000113231 | PDE8B | Phosphodiesterase 8B | [
"O95263"
] | 5 | 77210449-77428256 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036911",
"HPA036912"
] | [] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [
"Cushing syndrome",
"Disease variant"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Supported | null | null | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 32: Non-specific - Cell proliferation | Cluster 22: Non-specific - Basic cellular functions | Cluster 33: Thyroid gland - Tissue development | Tissue enriched | Detected in many | 4 | Low cancer specificity | Detected in some | null | Cancer enriched | Detected in many | 6 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 4,110 | 6 |
ENSG00000113240 | CLK4 | CDC like kinase 4 | [
"Q9HAZ1"
] | 5 | 178602664-178630615 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA043746"
] | [] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase",
"Tyrosine-protein kinase"
] | [] | [
"Actin filaments"
] | [] | [] | [] | Approved | Approved | null | 11 | No | No | Cluster 24: Non-specific - Transcription | Cluster 31: Non-specific - Transcription | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 90: Elongating spermatids - Spermiogenesis: Elongation | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,111 | 6 |
ENSG00000113249 | HAVCR1 | Hepatitis A virus cellular receptor 1 | [
"Q96D42"
] | 5 | 157026742-157069396 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA007173",
"CAB075697"
] | [
"CD365",
"HAVCR",
"HAVCR-1",
"KIM1",
"TIM-1",
"TIM1",
"TIMD1"
] | [
"CD markers",
"Predicted membrane proteins"
] | [
"Host-virus interaction"
] | [
"Host cell receptor for virus entry",
"Receptor"
] | [] | [
"Vesicles"
] | [] | [] | [] | Uncertain | Uncertain | null | 2 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 48: Non-specific - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 88: Proximal tubular cells - Transmembrane transport | Cluster 72: Kidney - Transmembrane transport | Group enriched | Detected in some | 5 | Cancer enriched | Detected in many | 4 | Group enriched | Detected in many | 13 | Cell type enriched | Detected in some | 5 | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 4,113 | 7 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.